BACE1: from biomarker to Alzheimer's disease therapeutical target.
作者信息
Cervellati Carlo, Valacchi Giuseppe, Zuliani Giovanni
机构信息
Department of Translational Medicine and for Romagna, University of Ferrara, Ferrara, 44121, Italy.
Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara, 44121, Italy.
出版信息
Aging (Albany NY). 2021 May 11;13(9):12299-12300. doi: 10.18632/aging.203064.
Abstract
摘要
相似文献
1
BACE1: from biomarker to Alzheimer's disease therapeutical target.β-分泌酶1：从生物标志物到阿尔茨海默病治疗靶点
Aging (Albany NY). 2021 May 11;13(9):12299-12300. doi: 10.18632/aging.203064.
2
The β-Secretase Enzyme BACE1: A Biochemical Enigma for Alzheimer's Disease.β-分泌酶酶 1（BACE1）：阿尔茨海默病的生化之谜。
CNS Neurol Disord Drug Targets. 2020;19(3):184-194. doi: 10.2174/1871527319666200526144141.
3
Alternative Selection of β-Site APP-Cleaving Enzyme 1 (BACE1) Cleavage Sites in Amyloid β-Protein Precursor (APP) Harboring Protective and Pathogenic Mutations within the Aβ Sequence.淀粉样β蛋白前体（APP）中β位点APP裂解酶1（BACE1）裂解位点的替代选择，该APP在Aβ序列内具有保护性和致病性突变。
J Biol Chem. 2016 Nov 11;291(46):24041-24053. doi: 10.1074/jbc.M116.744722. Epub 2016 Sep 29.
4
Swedish mutant APP-based BACE1 binding site peptide reduces APP β-cleavage and cerebral Aβ levels in Alzheimer's mice.基于瑞典突变体淀粉样前体蛋白（APP）的β-分泌酶1（BACE1）结合位点肽可降低阿尔茨海默病小鼠的APPβ切割及脑内淀粉样β蛋白（Aβ）水平。
Sci Rep. 2015 Jun 19;5:11322. doi: 10.1038/srep11322.
5
BACE1 SUMOylation deregulates phosphorylation and ubiquitination in Alzheimer's disease pathology.β-分泌酶1（BACE1）的类泛素化修饰在阿尔茨海默病病理学中失调磷酸化和泛素化过程。
J Neurochem. 2023 Jul;166(2):318-327. doi: 10.1111/jnc.15870. Epub 2023 Jun 7.
6
Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.泛素结合酶 1 在人类阿尔茨海默病和 APP/PS1 转基因小鼠脑及基于细胞模型中的关系。
Neurobiol Dis. 2016 Jan;85:187-205. doi: 10.1016/j.nbd.2015.11.005. Epub 2015 Nov 10.
7
The role of membrane trafficking in the processing of amyloid precursor protein and production of amyloid peptides in Alzheimer's disease.膜转运在阿尔茨海默病中淀粉样前体蛋白加工和淀粉样肽产生中的作用。
Biochim Biophys Acta Biomembr. 2019 Apr 1;1861(4):697-712. doi: 10.1016/j.bbamem.2018.11.013. Epub 2019 Jan 11.
8
MiR-340 Reduces the Accumulation of Amyloid-β Through Targeting BACE1 (β-site Amyloid Precursor Protein Cleaving Enzyme 1) in Alzheimer's Disease.miR-340 通过靶向 BACE1（β-淀粉样前体蛋白裂解酶 1）减少阿尔茨海默病中淀粉样β的积累。
Curr Neurovasc Res. 2020;17(1):86-92. doi: 10.2174/1567202617666200117103931.
9
Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.淀粉样β蛋白（Aβ）Glu11 是β-位淀粉样前体蛋白裂解酶 1（BACE1）的主要β-分泌酶位点，将裂解位点转移到 Aβ Asp1 有助于阿尔茨海默病的发病机制。
Eur J Neurosci. 2013 Jun;37(12):1962-9. doi: 10.1111/ejn.12235.
10
A new way APP mismetabolism can lead to Alzheimer's disease.APP代谢异常的一种新方式可能导致阿尔茨海默病。
EMBO Mol Med. 2011 May;3(5):247-8. doi: 10.1002/emmm.201100139. Epub 2011 Apr 27.
引用本文的文献
1
The manipulator behind "Scissors": γ -secretase and its modulators in Alzheimer's disease.“剪刀”背后的操纵者：γ-分泌酶及其在阿尔茨海默病中的调节剂
Front Aging Neurosci. 2025 Aug 25;17:1637671. doi: 10.3389/fnagi.2025.1637671. eCollection 2025.
2
Reducing Nogo-B Improves Hepatic Fibrosis by Inhibiting BACe1-Mediated Autophagy.抑制 BACE1 介导的自噬减少 Nogo-B 可改善肝纤维化。
Tissue Eng Regen Med. 2024 Jul;21(5):777-789. doi: 10.1007/s13770-024-00641-5. Epub 2024 Apr 17.
3
Discerning the Prospects of miRNAs as a Multi-Target Therapeutic and Diagnostic for Alzheimer's Disease.鉴别 miRNA 作为阿尔茨海默病多靶点治疗和诊断的前景。
Mol Neurobiol. 2023 Oct;60(10):5954-5974. doi: 10.1007/s12035-023-03446-0. Epub 2023 Jun 29.
4
Increased Serum Beta-Secretase 1 Activity is an Early Marker of Alzheimer's Disease.血清β-分泌酶 1 活性升高是阿尔茨海默病的早期标志物。
J Alzheimers Dis. 2022;87(1):433-441. doi: 10.3233/JAD-215542.
本文引用的文献
1
The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers.采用 AD 生物标志物 5 阶段开发框架评估淀粉样蛋白和磷酸化 tau 血液生物标志物的验证状态。
Eur J Nucl Med Mol Imaging. 2021 Jul;48(7):2140-2156. doi: 10.1007/s00259-021-05253-y. Epub 2021 Mar 6.
2
Plasma β-secretase1 concentrations correlate with basal forebrain atrophy and neurodegeneration in cognitively healthy individuals at risk for AD.血浆β-分泌酶 1 浓度与 AD 高危认知健康个体的基底前脑萎缩和神经退行性变相关。
Alzheimers Dement. 2021 Apr;17(4):629-640. doi: 10.1002/alz.12228. Epub 2021 Feb 1.
3
Increased blood BACE1 activity as a potential common pathogenic factor of vascular dementia and late onset Alzheimer's disease.血液 BACE1 活性升高可能是血管性痴呆和迟发性阿尔茨海默病的共同潜在致病因素。
Sci Rep. 2020 Sep 11;10(1):14980. doi: 10.1038/s41598-020-72168-3.
4
Is It the Twilight of BACE1 Inhibitors?β-分泌酶1（BACE1）抑制剂的黄昏时刻来临了吗？
Curr Neuropharmacol. 2021;19(1):61-77. doi: 10.2174/1570159X18666200503023323.
5
The β-Secretase BACE1 in Alzheimer's Disease.阿尔茨海默病中的β-分泌酶 BACE1。
Biol Psychiatry. 2021 Apr 15;89(8):745-756. doi: 10.1016/j.biopsych.2020.02.001. Epub 2020 Feb 13.
6
Serum beta-secretase 1 (BACE1) activity as candidate biomarker for late-onset Alzheimer's disease.血清β-分泌酶 1（BACE1）活性作为迟发性阿尔茨海默病的候选生物标志物。
Geroscience. 2020 Feb;42(1):159-167. doi: 10.1007/s11357-019-00127-6. Epub 2019 Nov 19.
7
Alzheimer's disease drug development pipeline: 2019.2019年阿尔茨海默病药物研发进程
Alzheimers Dement (N Y). 2019 Jul 9;5:272-293. doi: 10.1016/j.trci.2019.05.008. eCollection 2019.
8
Amyloid precursor protein processing and Alzheimer's disease.淀粉样前体蛋白的加工与阿尔茨海默病。
Annu Rev Neurosci. 2011;34:185-204. doi: 10.1146/annurev-neuro-061010-113613.
Zotero 插件